-
1
-
-
23844468090
-
Drug-induced pancreatitis: An update
-
DOI 10.1097/01.mcg.0000173929.60115.b4
-
Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol 2005; 39: 709-16. [CrossRef ] [Medline] [Web of Science] (Pubitemid 41177092)
-
(2005)
Journal of Clinical Gastroenterology
, vol.39
, Issue.8
, pp. 709-716
-
-
Trivedi, C.D.1
Pitchumoni, C.S.2
-
2
-
-
0019799332
-
A method for estimating the probability of adverse drug reactions
-
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45. [Medline] [Web of Science] (Pubitemid 12149145)
-
(1981)
Clinical Pharmacology and Therapeutics
, vol.30
, Issue.2
, pp. 239-245
-
-
Naranjo, C.A.1
Busto, U.2
Sellers, E.M.3
-
3
-
-
0034235806
-
Acute pancreatitis attributed to the use of interferon alfa-2b
-
Eland IA, Rasch MC, Sturkenboom MJ, et al. Acute pancreatitis attributed to the use of interferon alf a-2b. Gastroenterology 2000; 119: 230-3. [CrossRef ] [Medline] (Pubitemid 30452597)
-
(2000)
Gastroenterology
, vol.119
, Issue.1
, pp. 230-233
-
-
Eland, I.A.1
Rasch, M.C.2
Sturkenboom, M.J.C.M.3
Bekkering, F.C.4
Brouwer, J.T.5
Delwaide, J.6
Belaiche, J.7
Houbiers, G.8
Stricker, B.H.Ch.9
-
4
-
-
3543035786
-
Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C
-
DOI 10.1023/B:DDAS.0000034562.17003.50
-
Chaudhari S, Park J, Anand BS, et al. Acute pancreatitis associated with interferon and ribavirin therapy in patients with chronic hepatitis C. Dig Dis Sci 2004; 49: 1000-6. [CrossRef ] [Medline] [Web of Science] (Pubitemid 39012286)
-
(2004)
Digestive Diseases and Sciences
, vol.49
, Issue.6
, pp. 1000-1006
-
-
Chaudhari, S.1
Park, J.2
Anand, B.S.3
Pimstone, N.R.4
Dieterich, D.T.5
Batash, S.6
Bini, E.J.7
-
5
-
-
9244230558
-
Pancreatitis induced by pegylated interferon alfa-2b in a patient affected by chronic hepatitis C
-
Cecchi E, Forte P, Cini E, et al. Pancreatitis induced by pegy lated interferon alfa-2b in a patient affected by chronic hepatitis C. Emerg Med Australas 2004; 16: 473-5. [CrossRef ] [Medline] (Pubitemid 39551191)
-
(2004)
EMA - Emergency Medicine Australasia
, vol.16
, Issue.5-6
, pp. 473-475
-
-
Cecchi, E.1
Forte, P.2
Cini, E.3
Banchelli, G.4
Ferlito, C.5
Mugelli, A.6
-
6
-
-
34248162025
-
Acute pancreatitis associated with the use of peginterferon [5]
-
DOI 10.1097/MPA.0b013e3180333afb, PII 0000667620070500000020
-
Ozdogan O, Tahan V, Cincin A, et al. Acute pancreatitis associated with the use of peginterferon. Pancreas 2007; 34: 485-7. [CrossRef ] [Medline] [Web of Science] (Pubitemid 46725796)
-
(2007)
Pancreas
, vol.34
, Issue.4
, pp. 485-487
-
-
Ozdogan, O.1
Tahan, V.2
Cincin, A.3
Imeryuz, N.4
Tozun, N.5
-
7
-
-
0035796119
-
Mitochondrial toxic effects and ribavirin
-
[Medline] [Web of Science]
-
Salmon-Ceron D, Chauvelot-Moachon L, Abad S, et al. Mitochondrial toxic effects and ribavirin. Lancet 2001; 357: 803-4. [Medline] [Web of Science]
-
(2001)
Lancet
, vol.357
, pp. 803-804
-
-
Salmon-Ceron, D.1
Chauvelot-Moachon, L.2
Abad, S.3
-
8
-
-
0035064463
-
Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C
-
DOI 10.1136/gut.48.3.378
-
Wesche B, Jaeckel E, Trautwein C, et al. Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C. Gut 2001; 48: 378-83. [Abstract/FREE Full text] (Pubitemid 32269567)
-
(2001)
Gut
, vol.48
, Issue.3
, pp. 378-383
-
-
Wesche, B.1
Jaeckel, E.2
Trautwein, C.3
Wedemeyer, H.4
Falorni, A.5
Frank, H.6
Von Zur, M.A.7
Manns, M.-P.8
Brabant, G.9
-
9
-
-
84896281560
-
Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection
-
Search Google Scholar
-
Betterle C, Fabris P, Zanchetta R, et al. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection. Diabetes Care 2007; 16: 221-2. Search Google Scholar
-
(2007)
Diabetes Care
, vol.16
, pp. 221-222
-
-
Betterle, C.1
Fabris, P.2
Zanchetta, R.3
-
10
-
-
0034893193
-
Changes in serum lipoprotein profile during interferon therapy in chronic hepatitis C
-
DOI 10.1016/S0002-9270(01)02618-1, PII S0002927001026181
-
Naeem M, Bacon BR, Mistry B, et al. Changes in serum lipoprotein profile during interf eron therapy in chronic hepatitis C. Am J Gastroenterol 2001; 96: 2468-72. [CrossRef ] [Medline] [Web of Science] (Pubitemid 32769213)
-
(2001)
American Journal of Gastroenterology
, vol.96
, Issue.8
, pp. 2468-2472
-
-
Naeem, M.1
Bacon, B.R.2
Mistry, B.3
Britton, R.S.4
Di, B.A.M.5
|